Transitions From Heart Disease to Cancer as the Leading Cause of Death in US States, 1999–2016

Abstract

IntroductionHeart disease has been the leading cause of death in the United States since 1910 and cancer the second leading cause of death since 1933. However, cancer emerged recently as the leading cause of death in many US states. The objective of this study was to provide an in-depth analysis of age-standardized annual state-specific mortality rates for heart disease and cancer.MethodsWe used population-based mortality data from 1999 through 2016 to compare 2 underlying cause-of-death categories: diseases of heart (International Classification of Diseases, 10th Revision [ICD-10] codes I00–I09, I11, I13, and I20–I51) and malignant neoplasms (ICD-10 codes C00–C97). We calculated age-standardized annual state-specific mortality rate ratios (MRRs) as heart disease mortality rate divided by cancer mortality rate.ResultsIn 1999, age-standardized heart disease mortality exceeded that for cancer in all 50 states. Median state-specific MRR in 1999 was 1.26 (interquartile range [IQR], 1.17–1.34; range, 1.03–1.56), indicating predominance of heart disease mortality nationwide. Median state-specific MRR decreased annually through 2010, reaching a low of 1.00 (IQR, 0.95–1.07; range, 0.71–1.25), indicating that predominance of heart disease mortality prevailed in approximately half of states. Median state-specific MRR increased to 1.03 (IQR, 0.97–1.12; range, 0.77–1.31) in 2016. In 2016, age-standardized cancer mortality exceeded that for heart disease in 19 states. State-level transitions were most apparent for people aged 65 to 84 and affected men, women, and all racial/ethnic groups.ConclusionState-level data indicated heterogeneity across US states in the predominance of heart disease mortality relative to cancer mortality. Timing and magnitude of transitions toward cancer mortality predominance varied by state.

Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy

“…In the United States, cancer is projected to soon overtake heart disease as the leading cause of death. 105,106 Already, cancer has surpassed heart disease as the leading cause of death in many US states (22 states as of 2014) 107,108 and among Hispanics and Asian Americans. 1,107 In addition, projected demographic changes and patterns of cancer diagnoses in the United States will shift not just the count but also the composition of survivors, with proportions of survivors from racial/ethnic minority groups increasing.…”

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors

“…Cancer is considered a worldwide health risk nowadays. It is the second driving cause of death in the world, and it is anticipated to be the primary cause of death in the upcoming years (Harding et al, 2018). The invention of novel small molecules that are both potent and selective antitumor agents continues to be a serious challenge to medicinal chemistry researchers (Zhong et al, 2014;Iyer, 2015;Lin et al, 2019).…”

Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy

“…Cancer has replaced cardiovascular disease as the leading cause of death in the United States 1 . Although many antitumor drugs have been developed, the global burden of cancer is still high.…”